Related references
Note: Only part of the references are listed.Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort
C. Gilham et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
Primary cervical screening with high risk human papillomavirus testing: observational study
Matejka Rebolj et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience
Olga Veijalainen et al.
CYTOPATHOLOGY (2019)
Does the 'equal management of equal risks' model cause overtreatment in patients with positive cervical cytology results for ASCUS/non-HPV16/18 oncogenic types?
Ibrahim Karaca et al.
DIAGNOSTIC CYTOPATHOLOGY (2019)
Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
Clare A. Aitken et al.
BMC MEDICINE (2019)
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology
Mark H. Stoler et al.
GYNECOLOGIC ONCOLOGY (2019)
Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy
Clare A. Aitken et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis
Ping Teresa Yeh et al.
BMJ GLOBAL HEALTH (2019)
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Joy Melnikow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Triage of high-risk HPV positive women in cervical cancer screening
Renee M. F. Ebisch et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2015)
Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening Interim Clinical Guidance
Warner K. Huh et al.
OBSTETRICS AND GYNECOLOGY (2015)
Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials
Claudia Pileggi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders
Murat Gok et al.
EUROPEAN JOURNAL OF CANCER (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Mark H. Stoler et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme
Ahti Anttila et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Jack Cuzick et al.
VACCINE (2008)
Risk assessment to guide the prevention of cervical cancer
Philip E. Castle et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
High-risk HPV type-specific clearance rates in cervical screening
N. W. J. Bulkmans et al.
BRITISH JOURNAL OF CANCER (2007)
Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
Aagje G. Bais et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening
F Bray et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996
S Bulk et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Share Paper
